Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark, NJ 07103-6399, USA.
Oncogene. 2011 Nov 17;30(46):4645-55. doi: 10.1038/onc.2011.170. Epub 2011 May 23.
Here, we report the identification and characterization of a novel tyrosine phosphorylation site in the carboxy-terminal Src Homology 3 (SH3) (SH3C) domain of the Crk adaptor protein. Y251 is located in the highly conserved RT loop structure of the SH3C, a region of Crk involved in the allosteric regulation of the Abl kinase. Exploiting kinase assays to show that Y251 is phosphorylated by Abl in vitro, we generated affinity-purified antisera against phosphorylated Y251 in Crk and showed that Abl induces phosphorylation at Y251 in vivo, and that the kinetics of phosphorylation at Y251 and the negative regulatory Y221 site in vitro are similar. Y251 on endogenous Crk was robustly phosphorylated in chronic myelogenous leukemia cell lines and in A431 and MDA-MB-468 cells stimulated with epidermal growth factor. Using streptavidin-biotin pull downs and unbiased high-throughput Src Homology 2 (SH2) profiling approaches, we found that a pY251 phosphopeptide binds specifically to a subset of SH2 domains, including Abl and Arg SH2, and that binding of pY251 to Abl SH2 induces transactivation of Abl 1b. Finally, the Y251F Crk mutant significantly abrogates Abl transactivation in vitro and in vivo. These studies point to a yet unrealized positive regulatory role resulting from tyrosine phosphorylation of Crk, and identify a novel mechanism by which an adaptor protein activates a non-receptor tyrosine kinase by SH2 domain displacement.
在这里,我们报道了一种新型酪氨酸磷酸化位点在 Crk 衔接蛋白羧基末端Src 同源结构域 3(SH3)(SH3C)的鉴定和特征。Y251 位于 SH3C 的高度保守的 RT 环结构中,该区域涉及 Abl 激酶的变构调节。利用激酶测定法表明,Y251 在体外被 Abl 磷酸化,我们生成了针对 Crk 中磷酸化 Y251 的亲和纯化抗血清,并表明 Abl 在体内诱导 Y251 磷酸化,并且 Y251 和体外负调节 Y221 位点的磷酸化动力学相似。在慢性粒细胞白血病细胞系和表皮生长因子刺激的 A431 和 MDA-MB-468 细胞中,内源性 Crk 的 Y251 被强烈磷酸化。使用链霉亲和素-生物素下拉和无偏高通量Src 同源结构域 2(SH2)分析方法,我们发现 pY251 磷酸肽特异性结合到一组 SH2 结构域,包括 Abl 和 Arg SH2,并且 pY251 与 Abl SH2 的结合诱导 Abl 1b 的转激活。最后,Y251F Crk 突变体显著阻断了体外和体内的 Abl 转激活。这些研究指出了一种尚未实现的正调节作用,源于 Crk 的酪氨酸磷酸化,并确定了一种通过 SH2 结构域位移激活非受体酪氨酸激酶的新型机制。